AI Strategy & Leadership Practical insights
Ask what an autonomous campaign actually completes
Evaluate autonomous campaign claims by the decisions covered, exceptions handled and repeatable outcomes, rather than accepting a broad product label.
Calling a campaign autonomous can conceal major differences in what the system actually does. One product may draft assets; another may propose targeting; a third may execute approved changes. A leadership review should translate the label into a defined operating claim before comparing products or announcing a new organizational capability.
Ask for the complete task boundary
Request a start condition, supported decisions and a verifiable end state. Does the system stop at recommendations, submit work for approval or publish? Which channels, markets and account types are covered? Salesforce’s 2026 announcement includes different agents and rollout states, illustrating why a broad announcement cannot be treated as one uniformly available capability. [1]
Inspect the exceptions
Ask what happens when source data is missing, a creative claim is unsupported or a platform rejects an action. Identify which cases require people and how often that happened in comparable testing. A system can be valuable with substantial human involvement, but that involvement should remain visible in the operating description and cost.
Demand repeated outcome evidence
Request demonstrations across representative campaign conditions, not only a prepared ideal example. Check the final campaign state, approved constraints and the record of interventions. Where performance is claimed, distinguish task completion from incremental commercial impact. Reliably launching a campaign does not establish that it outperforms an alternative strategy.
Use a precise description in the decision
Replace the broad label with wording such as ‘prepares campaign assets and submits them for review’ if that is what evidence supports. Record unsupported areas and the next evaluation needed. Keep evidence of what the system can do separate from approval of what it may do. That distinction helps executives assess capability without authorizing business commitments on the strength of a product name alone.
Sources and evidence
Sources checked on 4 October 2026. Proposed workflows and hypothetical examples are editorial analysis.
From insight to practice